,,,
.. , .. , .. , , .
, . , , [4, 5, 8].
, HLA , , , [1, 3, 5, 6, 9].
, .
17 (34 ) 1042 . , , , .
Җ , Җ ( CD3, CD4, CD8, CD4/CD8, CD16, CD19) [7], Ö [2], [14]. (a) (S) [10]. [15]. (.. , 1988).
52 .
HLABw22, HLADRMT3, HLADR4 [1113].
.
() 35 56 29,4% (c2) 4,87 6,60 . (Px) HLA 35 56. HLA 12, 14, 22, 51, 18, 21, 27, 41; 7, 8, 16, 40 . (HLA A1A11) (. 1).
, 12, 14 , 22, 35, 51, 56 . 35 56 . HLA 2.
3. (n=4) 12 14 . (n=13) , (n=5) .
HLA 12 14 (<0,001) CD4+ CD16+ (p<0,05). 22, 35, 51, 56 (p<0,05) CD3+, CD8+, CD16+ CD19+ , . .
15 (87%), IgG (20,70,95 /) Ig (2,260,03 /), 11,630,25 1,640,061 /.
, , S, a, (. 4). 11 (64,7%), 12 (70,6%) 6 (35,3%) .
, .
, 12, 14, 22, 35, 51, 56 , . , , G . .
1. .. HLA . , 1999. 194 .
2. .., .., .. . // . . . ., 1989. 40 .
3. .. . ., , 1983. 208 .
4. .., .. (, ). ., 1998. 203.
5. .. , : . . ... ... , 2000. 22 .
6. .. , . //. .1998. 4. . 229301.
7. .. . // . . 1978. 7. . 8 15.
8. .., .., .., .. . //. . 1991. 4. . 4953
9. .., ..//Int. J.Immunorehabil. 1998. 10. . 3038.
10. .., .., .., .. // . , 1998. . 273277.
11. Bodmer W. //HLA 1997 Eds P.Terasaki, D.Gjertson. 1998. P. 17.
12. Boutimzine N., Laghmari A., Ouazzani I., Ibrahimy W., Mohcine Z. // J. Fr. Ophtalmol. 1998. Dec; 21 (10). P. 746754
13. DesarnauldsA.B., BorruatF.X., HerbortC.P., SpertiniF. //Klin.Monatsbl.Augenheilkd. 1996. May. 208 (5). P. 301302
14. Mancini G. et al. //Int. Immunochem. 1965. Vol .2 .235254.
15. Terasaki P.I., Bernoco D., Park M.S. et al. //Amer.J.Clin.Pathol. 1978. Vol. 69. P. 103120
Copyright (c) 2024 Stud-Baza.ru , , , .